A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh

Bangladesh remains cholera endemic with biannual seasonal peaks causing epidemics. At least 300,000 severe cases and over 4,500 deaths occur each year. The available oral cholera vaccineshave not yet been adopted for cholera control in Bangladesh due to insufficient number of doses available for end...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2022-01, Vol.40 (4), p.640-649
Hauptverfasser:	Chowdhury, Fahima, Akter, Afroza, Bhuiyan, Taufiqur Rahman, Tauheed, Imam, Teshome, Samuel, Sil, Arijit, Park, Ju Yeon, Chon, Yun, Ferdous, Jannatul, Basher, Salima Raiyan, Ahmed, Faez, Karim, Mahbubul, Ahasan, Mohammad Mainul, Mia, Masudur Rahman, Masud, Mir Mohammad Ibna, Khan, Abdul Wahab, Billah, Masum, Nahar, Zebun, Khan, Imran, Ross, Allen G., Kim, Deok Ryun, Ashik, Md. Muktadir Rahman, Digilio, Laura, Lynch, Julia, Excler, Jean-Louis, Clemens, John D., Qadri, Firdausi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adverse events Age Antibodies Antibodies, Bacterial Bangladesh - epidemiology Cholera Cholera - epidemiology Cholera - prevention & control Cholera Vaccines Cholvax Clinical trial Clinical trials Disease Enrollments Health care Humans Immunization Immunogenicity Infant Non-inferiority OCV Oral vaccines Pathogens Pharmacists Phlebotomy Public private partnerships Serotypes Vaccines Vaccines, Inactivated - adverse effects Vibrio cholerae O1 Waterborne diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!